Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma
- 1 August 2000
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 86 (3) , 203-207
- https://doi.org/10.1046/j.1464-410x.2000.00792.x
Abstract
Objectives To better define the relationship between platelet count and survival using a retrospective analysis in patients with thrombocytosis and metastatic renal cell carcinoma (RCC), some of who...Keywords
This publication has 27 references indexed in Scilit:
- Prognostic Significance of Nucleolar Organizer Region (AgNOR) in Renal Cell CarcinomaJournal of Urology, 1995
- Commentary on Prognostic Factors in Renal Cell CarcinomaJournal of Urology, 1995
- Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-αEuropean Journal Of Cancer, 1994
- Elevated serum interleukin‐6 levels in patients with reactive thrombocytosisBritish Journal of Haematology, 1991
- Classic and Modern Prognostic Indicators in Renal Cell CarcinomaUrologia Internationalis, 1991
- Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinomaThe Lancet, 1990
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Antimetastatic effects associated with platelet reduction.Proceedings of the National Academy of Sciences, 1968
- Thrombocytosis Associated With Malignant DiseaseArchives of internal medicine (1960), 1964